Aegerion Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAegerion Pharmaceuticals

Aegerion Pharmaceuticals(AEGR)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

breast neoplasms

,

non-small-cell lung carcinoma

Histone-arginine methyltransferase carm1

squamous cell carcinoma of head and neck

,

healthy volunteers/patients

,

squamous cell carcinoma

,

triple negative breast neoplasms

,

,

head and neck neoplasms

,

,

colorectal neoplasms

,

,

parkinson disease

,

myeloid leukemia acute

,

squamous cell neoplasms

,

,

large b-cell lymphoma diffuse

,

b-cell chronic lymphocytic leukemia

,

non-hodgkin lymphoma

,

acute kidney injury

,

follicular lymphoma

,

liver cirrhosis

,

,

,

chronic hepatitis c

,

,

vascular surgical procedures

,

wounds and injuries

,

,

hairy cell leukemia

,

b-cell lymphoma marginal zone

,

pancreatic neoplasms

,

neoplasm metastasis

,

,

urologic neoplasms

,

transitional cell carcinoma

,

,

non-small-cell lung carcinoma

,

multiple myeloma

,

liver neoplasms

,

myelodysplastic syndromes

,

plasma cell neoplasms

,

ovarian neoplasms

,

hepatocellular carcinoma

,

,

,

takayasu arteritis

,

fallopian tube neoplasms

,

peritoneal neoplasms

,

polycythemia vera

,

duchenne muscular dystrophy

mucopolysaccharidoses

,

mucopolysaccharidosis i

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use